List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Male Hypogonadism - Overview
Male Hypogonadism - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Male Hypogonadism - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Male Hypogonadism - Companies Involved in Therapeutics Development
Allergan Plc
Beijing Fogangren Bio-Pharm Tech Co Ltd
Diurnal Group Plc
EndoCeutics Inc
IASO BioMed Inc
Lipocine Inc
M et P Pharma AG
Marius Pharmaceuticals LLC
Medlab Clinical Ltd
Merck & Co Inc
Mereo Biopharma Group Plc
MHB Labs
NHTherapeutics Inc
Solural Pharma ApS
TesoRx Pharma LLC
Transdermal Delivery Solutions Corp
Veru Inc
Viramal Ltd
Male Hypogonadism - Drug Profiles
chorionic gonadotropin ER - Drug Profile
corifollitropin alfa - Drug Profile
enclomiphene citrate - Drug Profile
IAS-167A - Drug Profile
Male Hypogonadism - Dormant Projects
Male Hypogonadism - Discontinued Products
Male Hypogonadism - Product Development Milestones
Featured News & Press Releases
Appendix

List of Tables
Number of Products under Development for Male Hypogonadism, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Male Hypogonadism - Pipeline by Allergan Plc, H1 2020
Male Hypogonadism - Pipeline by Beijing Fogangren Bio-Pharm Tech Co Ltd, H1 2020
Male Hypogonadism - Pipeline by Diurnal Group Plc, H1 2020
Male Hypogonadism - Pipeline by EndoCeutics Inc, H1 2020
Male Hypogonadism - Pipeline by IASO BioMed Inc, H1 2020
Male Hypogonadism - Pipeline by Lipocine Inc, H1 2020
Male Hypogonadism - Pipeline by M et P Pharma AG, H1 2020
Male Hypogonadism - Pipeline by Marius Pharmaceuticals LLC, H1 2020
Male Hypogonadism - Pipeline by Medlab Clinical Ltd, H1 2020
Male Hypogonadism - Pipeline by Merck & Co Inc, H1 2020
Male Hypogonadism - Pipeline by Mereo Biopharma Group Plc, H1 2020
Male Hypogonadism - Pipeline by MHB Labs, H1 2020
Male Hypogonadism - Pipeline by NHTherapeutics Inc, H1 2020
Male Hypogonadism - Pipeline by Solural Pharma ApS, H1 2020
Male Hypogonadism - Pipeline by TesoRx Pharma LLC, H1 2020
Male Hypogonadism - Pipeline by Transdermal Delivery Solutions Corp, H1 2020
Male Hypogonadism - Pipeline by Veru Inc, H1 2020
Male Hypogonadism - Pipeline by Viramal Ltd, H1 2020
Male Hypogonadism - Dormant Projects, H1 2020
Male Hypogonadism - Discontinued Products, H1 2020

List of Figures
Number of Products under Development for Male Hypogonadism, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020

Companies Mentioned
• Allergan Plc
• Beijing Fogangren Bio-Pharm Tech Co Ltd
• Diurnal Group Plc
• EndoCeutics Inc
• IASO BioMed Inc
• Lipocine Inc
• M et P Pharma AG
• Marius Pharmaceuticals LLC
• Medlab Clinical Ltd
• Merck & Co Inc
• Mereo Biopharma Group Plc
• MHB Labs
• NHTherapeutics Inc
• Solural Pharma ApS
• TesoRx Pharma LLC
• Transdermal Delivery Solutions Corp
• Veru Inc
• Viramal Ltd